Roche Molecular Systems Inc. Sustainability Profile
Roche Molecular Systems Inc., a subsidiary of the global healthcare leader Roche Holding AG, is headquartered in the United States and operates extensively across North America and Europe. Founded in 1995, the company has established itself as a key player in the molecular diagnostics industry, focusing on innovative solutions for disease detection and management. Roche Molecular Systems is renowned for its advanced diagnostic technologies, including PCR (polymerase chain reaction) and next-generation sequencing, which enable precise and timely results. Their commitment to research and development has led to significant milestones, including the launch of groundbreaking tests for infectious diseases and oncology. With a strong market position, Roche Molecular Systems continues to set industry standards, recognised for its contributions to personalised medicine and patient care. The company’s unique offerings and dedication to innovation solidify its reputation as a leader in molecular diagnostics.
DitchCarbon Score
How does Roche Molecular Systems Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Roche Molecular Systems Inc.'s score of 83 is higher than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Roche Molecular Systems Inc., headquartered in the US, currently does not report specific carbon emissions data for the most recent year, as indicated by the absence of emissions figures. The company is a current subsidiary of Roche Holding AG, which may influence its climate commitments and reporting practices. While Roche Molecular Systems Inc. has not set specific reduction targets or initiatives at its level, it inherits climate commitments and performance data from Roche Holding AG. This includes participation in the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), which are aimed at reducing greenhouse gas emissions across its operations. As a part of Roche Holding AG's broader sustainability strategy, the company is committed to addressing climate change and reducing its carbon footprint, although specific targets and achievements for Roche Molecular Systems Inc. have not been detailed. The absence of direct emissions data suggests that the company may still be in the process of establishing its own specific climate action framework, aligned with the overarching goals of its parent organisation.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 403,136,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 188,924,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Roche Molecular Systems Inc.'s Industry?
How Carbon Intensive is Roche Molecular Systems Inc.'s Location?
Roche Molecular Systems Inc.'s Scope 3 Categories Breakdown
Roche Molecular Systems Inc.'s Scope 3 emissions, which decreased by 8% last year and increased significantly since 2013, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 71% of Scope 3 emissions.
Top Scope 3 Categories
Roche Molecular Systems Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Roche Molecular Systems Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
